Anti-angiogenic treatments are divided in two groups: on one hand, angiogenesis inhibitors (acting by normalization of the existing tumor vascularisation and through a decreased formation of new blood vessels) and on the other hand, vascular disrupting agents (which can destroy pathologic vessels).